简

繁

Investor Relations

Circulars

Date Year  
2020.09.17 (1) PROPOSED CHANGE OF DOMICILE; (2) PROPOSED ADOPTION OF MEMORANDUM OF CONTINUANCE AND NEW BYE-LAWS; (3) PROPOSED REDUCTION OF SHARE PREMIUM ACCOUNT; (4) PROPOSED CAPITAL REORGANISATION; (5) PROPOSED CHANGE IN BOARD LOT SIZE; AND (6) NOTICE OF EXTRAORDINARY GENERAL MEETING
2020.09.11 MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN (I) CHINA REGENERATIVE MEDICINE TISSUE ENGINEERING LIMITED AND (II) CHINA REGENERATIVE HOSPITAL INVESTMENT MANAGEMENT LIMITED
2020.07.31 (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) EXTENSION OF GENERAL MANDATE TO ISSUE SHARES (3) RE-ELECTION OF RETIRING DIRECTORS (4) REFRESHMENT OF SCHEME MANDATE LIMIT AND (5) NOTICE OF ANNUAL GENERAL MEETING
2020.04.21 VERY SUBSTANTIAL DISPOSAL FURTHER SALE OF INTEREST IN A FUND AND NOTICE OF EGM
2020.03.27 (I) PLACING OF NEW SHARES UNDER SPECIFIC MANDATE; (II) CONNECTED TRANSACTION - ISSUE OF CONVERTIBLE BONDS; (III) PROPOSED RE-ELECTION OF DIRECTORS; AND (IV) NOTICE OF EGM

IR Contact

China Regenerative Medicine International Limited

A:

Rooms 3006–10, 30/F., China Resources Building, 26 Harbour Road, Wanchai, Hong Kong

E: info@crmi.hk|

T: +852 3966 8388 |

F: +852 2802 0026